A group of high-likelihood Alzheimer’s disease patients had higher mIns and higher postmortem GFAP staining than low-likelihood controls, although in the combined sample GFAP and mIns levels did not reach a statistical correlation (Murray et al., 2014). Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.